The emerging roles of YAP and TAZ in cancer
Toshiro Moroishi1, Carsten Gram Hansen1, Kun-Liang Guan1
1Department of Pharmacology and Moores Cancer Center, University of California, San Diego, La Jolla, California 92093, USA.
Abstract:
Yes-associated protein (YAP) and transcriptional co-activator with PDZ-binding motif (TAZ) are the major downstream effectors of the Hippo pathway, which regulates tissue homeostasis, organ size, regeneration and tumorigenesis. In this Progress article, we summarize the current understanding of the biological functions of YAP and TAZ, and how the regulation of these two proteins can be disrupted in cancer. We also highlight recent findings on their expanding role in cancer progression and describe the potential of these targets for therapeutic intervention.
Insights
The Hippo pathway
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- The Hippo pathway is crucial for regulating tissue homeostasis and organ size.
- Yes-associated protein (YAP) and transcriptional co-activator with PDZ-binding motif (TAZ) are key downstream effectors of this pathway.
- Dysregulation of YAP and TAZ is implicated in various cancers.
Purpose of the Study:
- To summarize the biological functions of YAP and TAZ.
- To elucidate how YAP and TAZ regulation is disrupted in cancer.
- To highlight the therapeutic potential of targeting YAP and TAZ in cancer treatment.
Main Methods:
- Literature review of current research on YAP and TAZ.
- Analysis of the role of YAP and TAZ in cancer progression.
- Evaluation of YAP and TAZ as therapeutic targets.
Main Results:
- YAP and TAZ play significant roles in tissue homeostasis, organ size, regeneration, and tumorigenesis.
- Disrupted regulation of YAP and TAZ is a common feature in cancer development.
- Emerging evidence points to the expanding role of YAP and TAZ in driving cancer progression.
Conclusions:
- YAP and TAZ are critical regulators with implications in cancer biology.
- Targeting YAP and TAZ presents a promising avenue for novel cancer therapies.
- Further research is needed to fully exploit their therapeutic potential.
More Related Videos
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
09:55All-optical Mechanobiology Interrogation of Yes-associated Protein in Human Cancer and Normal Cells using a Multi-functional System
Published on: December 20, 2021
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Adaptive Mechanisms in Cancer Cells
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The Tumor Microenvironment
The Tumor Microenvironment
